Health Care Financing calls for papers / publications

Call for Papers for a Special Issue of the International Journal of Disability, Community & Rehabilitation: What Sorts of People Should There Be?

Guest Editor

Gregor Wolbring, Community Rehabilitation and Disability Studies, Dept. of Community Health Sciences, University of Calgary

Throughout history, people with non-normative abilities have been judged. Sometimes this judgment led to positive consequences, however for the most part these non-normative abilities were judged negatively and the carriers of such non-normative abilities experienced disabling treatment. This very judgment (ableism) and its disabling consequences is one of the main areas of scholarly work within the realm of disability studies. Eugenics, the practice of finding ways to better heritable abilities of humans, is one dynamic that influences the judgment of people’s abilities and the disabling consequences and vice versa.

What sorts of people should there be is a question that has been asked and answered in different ways throughout human history, is still a question asked and answered today and will be with us also for some time in the future.

Advances in science and technology will allow new judgments and actions linked to the sentiment around the question of what sorts of people there should be.

In partnership with the SSHRC-CURA-funded project “Living Archives on Eugenics in Western Canada” (eugenicsarchive.ca), the Editors of IJDCR would like to devote a special issue on this topic.

We invite potential contributors, regardless of fields of study (discipline), to submit 250-word abstracts that articulate the conceptual arguments and knowledge base to be covered in a critical analysis on various aspects from history to future of “What sorts of people should there be”.

Please submit abstracts to the Guest Editor via e-mail at gwolbrin[at]ucalgary.ca by 15 July, 2012

From selected abstracts, we will request full articles of 3000-5000 words (excluding figures and tables) of original research and scholarship on a range of topics to be submitted to the editor by 15 October 2012. Note that an invitation to submit an article does not guarantee its publication.

Every submitted article will be subject to blind peer review and recommendations arising.

As to possible areas linked to the theme the below is a sample list of possible topics

What sorts of people should be born
What sorts of people should live
What sorts of people should be citizens
What sorts of people should compete
What sorts of people….

We invite authors to investigate the history, contemporary use and potential future exhibition of the relationships between the core question “What sorts of people should there be” and such issues as:

disabled people and what it means to be ‘disabled’,
the community around them
practitioners, consumers and researchers linked to the disability discourse
community rehabilitation and the rehabilitation field in general
inclusive education and the education of disabled people in general
the future of education
employability of disabled people
citizenship of disabled people
global citizenship
body image of disabled people
medical and social health policies and their impact on disabled people
health care for disabled people
elderly people, youthism and ageism
disabled people in low income countries
laws and international conventions related to disabled people such as the UN Convention on the rights of persons with disabilities
the concept of personhood
concept of health and health care
the measure of disability adjusted life years and other measurements used to guide health care dollar allocation
quality of life assessment
history
future
science and technology governance
science and technology assessment
ethics
enhancement

For more information about the International Journal of Disability, Community & Rehabilitation (IJDCR) please go to http://www.ijdcr.ca.

International Journal of Disability, Community & Rehabilitation

www.ijdcr.ca

Call for Papers: Policy, Politics, & Nursing Practice

Get published! Submit your manuscript to Policy, Politics, & Nursing Practice

Benefits of Publishing in this Journal

Rigorous peer review of your work
Prompt publishing
Guaranteed targeted, multidisciplinary audience
High visibility for maximum global exposure

Now Indexed in MEDLINE!

Policy, Politics & Nursing Practice (PPNP) is a quarterly, peer-reviewed journal that explores the multiple relationships between nursing and health policy. PPNP serves as a major source of data-based study, policy analysis and discussion on timely, relevant policy issues for nurses in a broad variety of roles and settings, and for others who are interested in nursing-related policy issues.

Submit Manuscripts in these Areas

You are invited to submit your manuscript on a broad variety of topics and issues, including (but not limited to):

Impact of health system change and health reform on nurses and nursing practice;
Legislation and regulations affecting the nursing workforce and nurses’ practice environments;
Nurses’ roles as policy-makers--as legislators, agency officials, advocates and political leaders;
The roles of nursing organizations in shaping policy nationally and globally;
Policy issues currently under debate in the nursing profession;
Advancing solutions to health care disparities;
Health care financing and reimbursement issues;
Comparative analysis of global nursing issues;
Policy issues related to interdisciplinary practice, education and regulation.

We welcome research-based articles, commentary, policy analysis, discussion, book and film reviews and letters to the editor.

Call for Papers for a Special Issue of the Journal of Health & Productivity: Health and Productivity on the Workplace: the Relationship between Payer, Provider and Policy Maker in Oncology and Hematology

The deadline for submission is September 1, 2012.

The Journal of Health & Productivity (JHP) published by InPress Media Group for the Institute for Health and Productivity (IHPM) publishes current research and debate on all aspects of employee health and productivity.

The Journal of Health & Productivity aims to be the leading multidisciplinary publication offering peer-reviewed high quality original research and review articles with real relevance to payers, providers, policy makers and employers. The Journal provides corporate decision makers critically examined evidence applicable to their own issues concerning employee health and its impact on productivity.

Led by Editor-in-Chief William B. Bunn III, MD, JD, MPH, vice president of Health, Safety, Security and Productivity at Navistar International, the Journal’s Editorial Advisory Board of leading academic researchers and industry experts ensures that the publication is a must-read for researchers and practitioners concerned with the health and productivity of the workforce.

Reaching more than 12,000 senior executives via print and more than 9,500 electronically, the Journal of Health & Productivity heavily penetrates the market it serves, including corporate employee coalitions, business associations, health plans, providers and government agencies.

The Journal of Health & Productivity (JHP) publishes:

Peer-reviewed research articles on all aspects of employee health and productivity;
Practical advice via in-depth case studies, presenting simple practical solutions to employee health and productivity problems
Real-life implications for the individual, the employer, and public health systems in general
Policies, processes, systems and governance issues related to cost-effective health and productivity programs for employers.

Call for papers: Oncology & Hematology Special
The Journal of Health & Productivity (JHP) is planning to advance Journal of Health & Productivity further by publishing a special peer-reviewed issue addressing the topics relevant to the employer/payer and provider relationship in oncology and hematology.

Based on ongoing response from its members, the IHPM recognizes that there is an unfilled need for authoritative, peer reviewed, information about health and productivity related to oncology and hematology.

The Journal of Health & Productivity is seeking original work to facilitate understanding of the often divergent perspectives of payers, providers, policy makers and employers, presenting relevant – must-read – information that will enhance decisions made by providers, payers, and policy makers.

The Journal of Health & Productivity will be addressing unique oncology and hematology topics relevant to executives concerned about the health and productivity of their employees.

The overall goal of the Journal is to improve employee healthcare in the oncology and hematology.

The editors of the Journal of Health & Productivityare seeking original research articles and informed commentary on the following topics:

Cancer in the workplace: prevalence and economic impact

Measuring the economic burden of cancer

The impact of cancer and hematological disorders on workplace health and productivity

The psychosocial impact of cancer and hematological disorders and the effect on employee productivity

Lost productive time associated with cancer and hematological disorders

Measuring outcomes and quality of care and the impact on employee productivity

Cost of new therapeutic agents and impact on patients, employees, providers and employers

Effects of innovative models of care, care delivery, and quality of care on employee health and productivity

Effects of healthcare reform on cancer care – and how this impacts employers and employees

Methodologies for accountability of payers and providers in oncology/hematology and the effect on employers and employees

Effect on employee health and productivity of health promotion and care delivery models in oncology/hematology

Improving functional health of employees with cancer and their impact on total labor costs

Impact of new economic models on oncology care – and the effect on employee productivity

Effects of healthcare reform on cancer care on employee health and productivity

Impact of plan design on patient access to appropriate therapies

The benefit of integrating evidence-based guidelines into practice on employee health and productivity

Innovative collaboration between payers, providers, policy-makers and the effect on workplace health and productivity

Advances in the diagnosis and treatment of cancer and the impact on employee health and productivity

Cancer survivorship, late treatment-related side effects (physical, psychosocial and cognitive abnormalities) and employee health and productivity

How to submit
Preference will be given to high quality original research and review articles. Contributors are encouraged to report on current research, clarifying the practical implications on employee health and productivity of their work in order to increase understanding and provide a platform for further research and development.

All submitted papers will undergo the standard peer-review process required by Journal of Health & Productivity. Due to space constraints, please limit the text to 4500 words and the graphic elements to a combined total of 6 tables and figures. Final decisions regarding inclusion in this special issue rest solely with the Editors.

Please send your manuscript to:

Peter Hofland, PhD
Publisher and Executive Editor Journal of Health & Productivity
InPress Media Group, LLC
4960 South Gilbert Road, Suite 1286
Chandler, AZ 85249
editor@inpressmediagroup.com

Call for Papers for Two Special Issues of Palliative Medicine

Call for papers for two forthcoming special editions:

1. Family Carers in Palliative care
Guest edited by Prof Sheila Payne and Prof Gunn Grande

It is widely recognised that family, friends and significant others (hereafter called ‘family carers’) provide care to patients during advanced illness and through the process of dying. They have an essential role in providing physical care, emotional and social support, financial resources, advocacy and anticipatory care, and in negotiating and managing care during the final phases of life. The presence of family carers who are able and willing to provide care can facilitate patient choices, such as place of care and death at home. It is a challenging and demanding role which may have physical, psychological, social and financial consequences for carers which outlasts the period of care and may influence their bereavement. Family carers occupy an ambiguous position, being both providers and potentially recipients of care.

This proposed Special Edition will serve as a useful resource for everyone interested in improving support to family carers. It is written for researchers, clinicians, managers, educators and policy makers working in, or responsible for, palliative care and hospice services. The special edition will focus on care provided by adults to adults who are in the palliative phase of their condition. It will cover care provided in a range of settings including the home, hospital, care home (nursing home) for older people, hospice and other settings.

Such knowledge is essential for informing the construction, evaluation, and promotion of supportive interventions that promote well-being directly for family carers and indirectly for patients. Hence, the call for papers for this special issue invites theoretical and research-based manuscripts that address the cumulative and interactive effects of individual, family, community, organizations, services, and policy factors on family carers’ well-being. Thus we call for manuscripts that target research from health and social care perspectives with a primary focus on family carers within a context of palliative and end of life care.
Potential topics include, but are not limited to:

Promoting needs assessments of family carers with implications for targeting appropriate interventions
Identifying factors associated with adverse effects of care giving
Systematic reviews of the impact of carers interventions on outcomes
International or national comparisons of carers economic policies and their influence on health decision-making
Identifying the needs of specific groups of carers and their experiences

2. Understanding of palliative care in non-malignant disease
Guest edited by Prof Marie Fallon

In many countries specialist palliative care grew out of and has been closely associated with cancer care. This has led to challenges in providing palliative care for patients with non-malignant disease; knowledge, attitudes and skills have been strongly affected by this background. Modern palliative care in the cancer setting is more integrated than before and can move in and out of patient care, but this may not always be true for patients with other diagnoses.

This special edition will focus on developing our knowledge base regarding the palliative care of those with non-malignant disease. We particularly seek papers from those working outside specialist palliative care which add to our understanding of how palliative care can contribute to the care and meet the needs of those with non-malignant disease. Our aim is to publish rigorous empirical (original research or reviews), methodological or theoretical work to further our understanding of palliative care in non-malignant disease.

Potential topics include, but are not limited to:

Understanding what colleagues from non-palliative care specialties require from palliative care to meet the needs of different patient groups.

Learning from diverse health care settings and services across different counties about effective collaboration between palliative care and other specialties.

How to educate people to provide effective high quality palliative care to those with non-malignant disease.

The use of guidelines or national frameworks for providing end of life care to those with non-malignant disease.

The views of patients and carers on developments in non-malignant palliative care.

New methods of investigating these issues.

Before submission authors should carefully read the journal’s Author Guidelines http://www.uk.sagepub.com/journals/Journal201823?#tabview=manuscriptSubmission

Authors should submit an electronic copy of their complete manuscript through Manuscript Central: http://mc.manuscriptcentral.com/palliative-medicine. Submissions are encouraged by 1st October 2012. For further information please contact the Editorial Office: debbie.ashby@bristol.ac.uk

Guest Editors
Professor Sheila Payne
Director of the International Observatory on End of Life Care
Help the Hospices Chair in Hospice Studies
Lancaster University

Professor Gunn Grande
Professor of Palliative Care
School of Nursing, Midwifery & Social Work
University of Manchester

Professor Marie Fallon
St Columba’s Hospice Chair of Palliative Medicine
University of Edinburgh

Call for Papers for a Special Issue of the International Journal of Pharmaceutical and Healthcare Marketing: Pharmaceutical Direct-to-Consumer Advertising: Past, Present, and Future

Guest Editors: Dr Avinandan Mukherjee, Montclair State University, USA
Dr Yam B. Limbu, Montclair State University, USA

Pharmaceutical Direct-to-Consumer Advertising (DTCA) includes different types of promotional efforts employed by pharmaceutical companies to provide prescription drug information to the general public through consumer-oriented media. It is allowed currently only in the USA and New Zealand. In the past decade, pharmaceutical companies have been involved in intense direct-to-consumer advertising and promotion of prescription drugs. Spending on DTCA of prescription drugs has been accelerating. It grew from $2.5 billion in 2000 to $3.3 billion in 2003, $4.2 billion in 2005, and $4.5 billion in 2009. There was a 330 per cent increase in DTCA spending between 1996 and 2005. As a result, the average American television viewer spent about 16 hours annually watching prescription drug advertisements; that was far more time than they spent with their family physicians.

The environment in which the DTCA of prescription drugs operates is unique in two ways:

1 While consumers are targeted by DTC advertisers, only physicians have the right to prescribe the advertised drug; and

2 Considering the risks associated with prescription drugs, regulatory bodies and consumer protection agencies are more involved in approving and monitoring all DTCA communications.

Consumer segments based on a variety of characteristics, e.g. demographics and psychographics, such as health beliefs and health orientations, respond differently to various dimensions of DTCA communication, such as information, comprehension, trust and valence.

While DTCA has been credited for improvements in pharmaceutical sales growth, patient education, and improved health outcomes, it has been criticized for its role in drug over-utilization, public health concerns, higher drug costs, and physician dissonance. These issues become more paramount in the wake of the high involvement nature of prescription drugs, the average consumer's lack of scientific knowledge, and their propensity to self-diagnose and ask physicians for specific medications. DTCA is thus an extremely complex and yet a very important topic that deserves researchers' sincere attention.

It has been an issue of intense public policy attention and debate since the early years of its existence. Unfortunately, it is one of the most understudied areas in pharmaceutical and healthcare marketing. Empirical research on the effect of DTCA is especially scarce. Much of the extant research on DTCA is exploratory in nature, mostly based on literature reviews and using content analysis as the methodology. Comprehensive and empirically validated models of consumer responses to DTCA are still rare in the literature and little is known about its effects on the attitudes and behaviour of concerned parties such as consumers,  physicians, nurses, and other healthcare providers.

Thus, the main goal of this IJPHM special issue is to address these research gaps. Authors are invited to submit empirical or conceptual papers that may have substantial practical and/or theoretical implications for various aspects of DTCA.

Topics for the special issue

Although manuscripts on any topic related to DTCA are welcome, papers on the following topics are highly encouraged:

-- Stakeholders' (e.g., consumers, physicians, nurses, salesforce) responses/attitudes to DTCA

-- Patient-physician interactions, communication, and relationships

-- Effect of DTCA on physician prescription behaviour

-- Information search from sources other than physicians as a result of DTCA (e.g., online search)

-- Other behavioral intentions (e.g., prescription request, intent to recommend, WOM)

-- Content of DTC advertisements (e.g., textual, pictorial)

-- Effect of DTCA expenditure on financial performance (e.g., price/sales/market share/ROI/shareholders' value)

-- Trend analysis of DTCA expenditures by product category and consumer segments

-- Role of internet and technology on DTCA (e.g., DTC web sites, blogs, social media etc--)

-- Risk disclosure and perceived risk

-- DTC claims or message credibility/source or media credibility/ perceived believability

-- Role of different types of message appeal, persuasion

-- Situation and context effects

-- Role of affect, cognition, and emotion

-- Role of different types of involvement, motivation, and individual differences

-- Role of consumer knowledge/expertise/familiarity

-- Consumer recall and memory

-- DTCA exposure, attention, and interpretation

-- Consumer learning, awareness, and literacy

-- Impact on drug and therapy compliance, non-compliance, and adherence

-- Effectiveness of different DTCA information sources (e.g., print, TV, online, radio, outdoor, direct mail)

-- Role of demographics on DTCA perceptions

-- Historical evolution and growth of DTCA

-- Ethical issues relating to DTCA

-- Government policy, laws, and regulations

-- Pharmaceutical industry's perspectives on impact of DTCA

-- Attitudes towards and likely adoption of DTCA in countries other than the USA and NZ

-- Macro impact of DTCA (e--g-- impact on economy, healthcare sector, healthy living, patient care)

-- Future of DTCA

Research methods

Quantitative and qualitative studies, including marketing and consumer behaviour models, experiments, correlational studies, causal studies, comparative studies, descriptive studies, literature reviews, meta-analysis, case studies, viewpoint articles, pedagogical innovations, and book reviews are all welcome. Papers can adopt a historical, current or future perspective.

Submission process

Manuscripts should be submitted no later than 30 June 2012. The special issue is expected to be published in early 2013. All manuscripts will be subjected to double-blind peer review and should follow the general guidelines for authors of the International Journal of Pharmaceutical and Healthcare Marketing, which can be found at:
www.emeraldinsight.com/ijphm.htm

Manuscripts should be submitted electronically to IJPHM editorial e-mail at: editor-ijphc@mail.montclair.edu

Please contact the Guest Editors of this special issue at the following e-mail addresses, if you have any questions:

Dr Avinandan Mukherjee
E-mail: mukherjeeav@mail.montclair.edu

and

Dr Yam Limbu
E-mail: limbuy@mail.montclair.edu